A PUTATIVE ROLE FOR BONE MORPHOGENETIC PROTEIN ANTAGONIST GREMLIN1 IN HER2 POSITIVE BREAST CANCERS

被引：0
|
作者：
Zabkiewicz, C. [1 ]
Ye, L. [1 ]
Hargest, R. [1 ]
机构：
[1] Cardiff Univ, Cardiff China Med Res Collaborat, Cardiff, S Glam, Wales
来源：
BRITISH JOURNAL OF SURGERY | 2019年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O17
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [21] HercepTest for the Detection of HER2 Protein Overexpression in Breast and Gastric Cancers
    Martinez, Laura
    Ward, Katie
    Honeywell, Marlon
    Welch, Tiffany
    US PHARMACIST, 2011, 36 (09) : HS25 - HS28
  • [22] Differential response of HER2 positive breast cancer based on HER2 protein expression level
    Atallah, N. M.
    Toss, M. S.
    Al Saleem, M.
    Green, A. R.
    Mongan, N. P.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2023, 261 : S9 - S9
  • [23] Role of endocrine therapy in ER+/HER2(+) breast cancers
    Webber, Victoria L.
    Dixon, J. Michael
    BREAST CANCER MANAGEMENT, 2014, 3 (01) : 103 - 111
  • [24] Estrogen and progesterone hormone receptor status in HER2 positive breast cancers
    Kubelka-Sabit, K.
    Filipovski, V.
    Karagjozov, M.
    Stojcevska-Capova, M.
    Jasar, D.
    VIRCHOWS ARCHIV, 2015, 467 : S65 - S65
  • [25] Radiolabelled trastuzumab Fab as a theranostic molecule for HER2 positive breast cancers
    Rathore, Y.
    Shukla, J.
    Mittal, B. R.
    Singh, G.
    Gopal, K.
    Kumar, R.
    Bal, A.
    Laroiya, I.
    Lakhanpal, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S55 - S56
  • [26] Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California
    Lin, Chieh-Yu
    Carneal, Eugene E.
    Lichtensztajn, Daphne Y.
    Gomez, Scarlett L.
    Clarke, Christina A.
    Jensen, Kristin C.
    Kurian, Allison W.
    Allison, Kimberly H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 148 (03) : 199 - 207
  • [27] Hypoxia induces alternative activation ofmacrophages and increases their expression of the bone morphogenetic protein antagonist gremlin-1
    Mthunzi, L.
    Kubica, M.
    Knaus, U.
    McLoughlin, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S405 - S405
  • [28] The Role of Trastuzumab in Patients with HER2 Positive Small (pT1mi/a) Breast Cancers, a Multicenter Retrospective Study
    Villasco, Andrea
    Actis, Silvia
    Bounous, Valentina Elisabetta
    Borella, Fulvio
    D'Alonzo, Marta
    Ponzone, Riccardo
    De Sanctis, Corrado
    Benedetto, Chiara
    Biglia, Nicoletta
    CANCERS, 2021, 13 (22)
  • [29] HER2 0, HER2 1+and HER2 2+/FISH Negative Primary Breast Cancers Are Biologically Distinct
    Donahue, Nolan
    Aragao, Alessa
    Gordezky, Rachel
    Haddad, Sandra
    Tang, Ping
    LABORATORY INVESTIGATION, 2024, 104 (03) : S146 - S148
  • [30] Correlation of HER2 Immunohistochemical Scores and HER2 mRNA, Oncotype Recurrence Score and Magee Scores on ER Positive, HER2 Negative Breast Cancers
    Tyburski, Haley
    Karakas, Cansu
    Zhang, Huina
    Liu, Elena
    Turner, Bradley
    Hicks, David
    LABORATORY INVESTIGATION, 2023, 103 (03) : S216 - S217
12345